Exited company
Celator Pharmaceuticals Inc.
About the company
Celator is a biopharmaceutical company working to develop new and more effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents a revolutionary new approach to the development of combination therapies designed to target cancer cells. The company’s lead product is in clinical development for the treatment of acute myeloid leukemia.